Cover Image
市場調查報告書

末稍血管疾病手術產品:技術及全球市場

Peripheral Vascular Surgical Products: Technologies and Global Markets

出版商 BCC Research 商品編碼 296882
出版日期 內容資訊 英文 200 Pages
訂單完成後即時交付
價格
Back to Top
末稍血管疾病手術產品:技術及全球市場 Peripheral Vascular Surgical Products: Technologies and Global Markets
出版日期: 2014年02月28日 內容資訊: 英文 200 Pages
簡介

全球末稍血管疾病手術產品市場2012年達到了58億美元。一般認為該市場預計從2013年的62億美元到2018年的84億美元,以年複合成長率6.3%擴大。

本報告提供末稍血管疾病手術產品市場概要、2012年的資料為基礎的市場趨勢、2013年的預測、到2018年的成長率、各產品趨勢、該產業的大企業簡介等彙整資料,為您概述為以下內容。

第1章 簡介

第2章 摘要

第3章 末稍血管疾病的概要與末稍血管疾病手術

  • 末稍血管疾病概要
  • 末稍血管疾病的分類
  • 週邊動脈疾病
  • 頸動脈疾病及中風
  • 靜脈疾病
  • 血液透析機的動靜脈通路
  • 末稍血管疾病的治療
  • 血管內手術機器人的使用

第4章 血管新生球囊導管及相關設備市場

第5章 末稍血管疾病及頸動脈支架市場

第6章 血管內主動脈瘤血管支架市場

第7章 血管治療的經皮旋切術策略市場

第8章 血管血栓溶解及血栓切除系統市場

第9章 靜脈疾病治療及封閉設備市場

第10章 末梢繞道手術及AV側道的血管移植及貼片市場

第11章 栓塞保護裝置市場

第12章 末稍血管疾病的影響與末稍血管疾病手術的利用可能性

  • 簡介
  • 美國
  • 歐洲
  • 亞太地區

第13章 美國的專利分析

第14章 血管手術設備的合併、收購活動

第15章 企業簡介

圖表

目錄
Product Code: HLC160A

The global market for peripheral vascular surgical devices reached $5.8 billion in 2012. This market is projected to grow from $6.2 billion in 2013 to $8.4 billion in 2018 with a compound annual growth rate (CAGR) of 6.3% for the five-year period, 2013 to 2018.

This report provides:

  • An overview of the global market for peripheral vascular surgical devices
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Information on devices including surgical equipment, instruments, stents, grafts, patches, and other devices routinely used by vascular surgeons and interventional radiologists
  • A close look at why the market for these products is experiencing rapid growth as manufacturers compete with ever-evolving technologies
  • Comprehensive profiles of leading companies in the industry.

REPORT SCOPE

INTRODUCTION

RESEARCH GOALS AND OBJECTIVES

The goals of this BCC Research report are to explore the different factors affecting peripheral vascular surgery and the manufacture of peripheral vascular devices, as well as to quantify the market for various segments of the peripheral vascular device market. Vascular surgery is increasing globally, with the contribution of macroeconomic factors such as aging populations, increasing rates of obesity, poor nutrition and other health stressors, as well as improing availability of health services in developing countries. In recent years, new technologies have been developed that make sophisticated therapies accessible for patients in previously underserved locations.

REASONS FOR DOING THIS STUDY

The purpose of this report will be to describe and quantify the markets for medical devices used in the surgical and interventional treatment of peripheral vascular disease. Such devices include surgical equipment, instruments, stents, grafts, patches and other devices routinely used by vascular surgeons and interventional radiologists. Vascular disease will be defined to include:

  • Arterial disease related to the aortic, femoral, and subclavian arteries, peripheral arteries, and the carotid arteries.
  • Venous disease related to both deep veins and superficial veins.
  • Venous access for hemodialysis in end stage renal disease patients.

This report will identify areas of growth within the peripheral vascular surgical device market and will discuss innovative technologies that have been recently launched or are presently under development. Market growth rates are projected based on manufacturers' net revenues, unless otherwise indicated. This report excludes embolization devices, which often utilize an endovascular approach but are not always used to treat vascular disease. The report also excludes venous compression therapy products, which are used to treat venous disease but are not interventional in nature.

This report is designed to achieve the following objectives:

  • To describe the trends and developments affecting each type of peripheral vascular surgical technology and discuss how each addresses market needs.
  • To analyze market demand, competitive dynamics and regulatory/ reimbursement-related factors to project the market size for each technology and to highlight target applications.
  • To examine the competitors in the peripheral vascular surgical device business with respect to market position and product development.

This report is designed to appeal to many types of readers, including marketing and management executives within the medical device industry, venture capital professionals interested in exploring commercialization opportunities, and anyone else who would like to better understand how market factors and technologies interact in this industry.

SCOPE OF REPORT

The scope of this study encompasses multiple technologies and procedures related to peripheral vascular surgical devices. BCC Research analyzes the industry on a worldwide basis from market, product and technology perspectives. Regulations and reimbursement issues and patents issued from 2010 through the end of 2013 are also examined to identify patient safety, regulatory review and insurance coverage issues for stakeholders and potential stakeholders in this industry. The report examines the peripheral vascular surgery device industry in general, the types of technologies currently in use as well as future technological developments, and regulatory influences that affect product distribution. The industry structure section discussed the most active manufacturers with respect to relative market share, marketing strengths and forces that promote or hinder the growth of technologies. The technology sections detail historical, current (2013) and projected (2013 to 2018) market values.

Table of Contents

CHAPTER 1 INTRODUCTION

  • RESEARCH GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • RELATED BCC RESEARCH PUBLICATIONS
  • BCC RESEARCH ONLINE SERVICES
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • SUMMARY TABLE 1 PROJECTED GLOBAL MARKET FOR PERIPHERAL VASCULAR SURGICAL DEVICES, THROUGH 2018 ($ MILLIONS)
  • SUMMARY TABLE 2 ESTIMATED MARKET SHARES BY MANUFACTURER, 2012 ($ MILLIONS/%)
  • SUMMARY FIGURE ESTIMATED MARKET SHARES BY WORLD REGION, 2012 AND PROJECTED 2018 (%)

CHAPTER 3 OVERVIEW OF PERIPHERAL VASCULAR DISEASE AND PERIPHERAL VASCULAR SURGERY

  • OVERVIEW OF PERIPHERAL VASCULAR DISEASE
  • CATEGORIES OF PERIPHERAL VASCULAR DISEASE
  • TABLE 1 LEADING PERIPHERAL VASCULAR DISEASE CONDITIONS
  • PERIPHERAL ARTERY DISEASE (PAD)
    • DESCRIPTION OF ATHEROSCLEROSIS AND PERIPHERAL ARTERY DISEASE
    • PREVALENCE OF PERIPHERAL ARTERY DISEASE
    • RISK FACTORS AND SYMPTOMS OF PERIPHERAL ARTERY DISEASE
    • DIAGNOSTIC EVALUATION OF PERIPHERAL ARTERY DISEASE
    • ASSESSMENT OF VULNERABLE ATHEROSCLEROTIC PLAQUES
    • TABLE 2 INVASIVE TECHNIQUES FOR IMAGING THE VULNERABLE PLAQUE
    • TABLE 3 NONINVASIVE TECHNIQUE FOR IMAGING THE VULNERABLE PLAQUE
  • ARTERIAL ANEURYSMAL DISEASE
    • DESCRIPTION OF AORTIC ANEURYSM (ABDOMINAL AND THORACIC)
    • DESCRIPTION OF PERIPHERAL ANEURYSM
  • ARTERIAL ANEURYSMAL DISEASE
    • DESCRIPTION OF AORTIC ANEURYSM (ABDOMINAL AND THORACIC)
    • DESCRIPTION OF PERIPHERAL ANEURYSM
    • PREVALENCE OF ANEURISMAL ARTERIAL DISEASE
    • SYMPTOMS OF ANEURISMAL ARTERIAL DISEASE
    • DIAGNOSTIC EVALUATION OF ANEURISMAL ARTERIAL DISEASE
  • CAROTID ARTERY DISEASE AND STROKE
    • DESCRIPTION OF CAROTID ARTERY DISEASE AND STROKE
    • PREVALENCE AND INCIDENCE OF STROKE
    • RISK FACTORS AND SYMPTOMS OF CAROTID ARTERY DISEASE
    • DIAGNOSTIC EVALUATION OF CAROTID ARTERY DISEASE
  • VENOUS DISEASE
    • TYPES OF VENOUS DISEASE
    • PREVALENCE AND INCIDENCE OF VENOUS DISEASE
    • RISK FACTORS AND SYMPTOMS OF CHRONIC VENOUS INSUFFICIENCY
    • DIAGNOSTIC EVALUATION OF VENOUS DISEASE
  • ARTERIO-VENOUS (AV) ACCESS FOR HEMODIALYSIS
    • DESCRIPTION OF ARTERIO-VENOUS (AV) ACCESS
    • AV ACCESS PROCEDURE STATISTICS
  • TREATMENT OF PERIPHERAL VASCULAR DISEASE
    • LIFESTYLE CHANGES AND MEDICAL THERAPY
    • COMPRESSION THERAPY
    • OPEN VASCULAR SURGERY
      • Surgical Bypass
      • Endarterectomy
      • Surgical Aortic Aneurysm Repair
      • Amputation
      • Vein Stripping and Ambulatory Phlebectomy
    • ENDOVASCULAR SURGERY
      • Percutaneous Transluminal Angioplasty (PTA)
      • Endovascular Stenting
      • Percutaneous Atherectomy
      • Endovascular Embolectomy and Thrombectomy
      • Endovascular Aneurysm Repair
      • Endovenous Closure Treatments
  • USE OF ROBOTICS IN ENDOVASCULAR SURGERY

CHAPTER 4 GLOBAL MARKETS FOR ANGIOPLASTY (PTA) BALLOON CATHETERS AND RELATED DEVICES

  • TREATMENT OPTIONS FOR PERIPHERAL ARTERY DISEASE
  • TABLE 4 ESTIMATED NUMBER OF PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE, U.S. ONLY, 2012
  • MANUFACTURERS OF PTA BALLOON CATHETERS
    • ABBOTT VASCULAR
    • BARD PERIPHERAL VASCULAR
    • BAYER INTERVENTIONAL
    • BOSTON SCIENTIFIC
    • CORDIS ENDOVASCULAR
    • COVIDIEN
    • MEDTRONIC ENDOVASCULAR
  • MANUFACTURERS OF PERIPHERAL GUIDEWIRES
    • ABBOTT VASCULAR
    • BOSTON SCIENTIFIC
  • GLOBAL MARKET FOR PTA CATHETERS AND RELATED PRODUCTS
  • FIGURE 1 ESTIMATED MARKET SHARE OF PTA CATHETERS AND RELATED PRODUCTS BY GEOGRAPHIC REGION, 2012 (%)
  • TABLE 5 PROJECTED GLOBAL MARKET FOR PTA CATHETERS, GUIDEWIRES, AND RELATED DEVICES, THROUGH 2018 ($ MILLIONS)

CHAPTER 5 GLOBAL MARKET FOR PERIPHERAL VASCULAR AND CAROTID STENTS

  • CLINICAL NEED FOR PERIPHERAL VASCULAR STENTS
  • MANUFACTURERS OF PERIPHERAL VASCULAR STENT SYSTEMS
    • 480 BIOMEDICAL
    • ABBOTT VASCULAR
    • BARD PERIPHERAL VASCULAR
    • BOSTON SCIENTIFIC
    • COOK MEDICAL
    • CORDIS ENDOVASCULAR
    • COVIDIEN
    • MEDRONIC
    • ZORION MEDICAL
  • CLINICAL NEED FOR CAROTID ARTERY STENTS
  • MANUFACTURERS OF CAROTID ARTERY STENT SYSTEMS
    • CORDIS ENDOVASCULAR
    • COVIDIEN
    • GORE MEDICAL
  • GLOBAL MARKET FOR VASCULAR AND CAROTID ARTERY STENT SYSTEMS
  • FIGURE 2 ESTIMATED MARKET SHARE OF VASCULAR AND CAROTID ARTERY STENT SYSTEMS BY GEOGRAPHIC REGION, 2012 (%)
  • TABLE 6 PROJECTED GLOBAL MARKET FOR PERIPHERAL VASCULAR AND CAROTID ARTERY STENT SYSTEMS, THROUGH 2018 ($ MILLIONS)

CHAPTER 6 GLOBAL MARKETS FOR ENDOVASCULAR AORTIC ANEURYSM STENT GRAFTS

  • CLINICAL NEED FOR AORTIC ANEURYSM STENT GRAFTS
  • MANUFACTURERS OF STENT GRAFTS FOR EVAR
    • APTUS ENDOSYSTEMS
    • COOK MEDICAL
    • ENDOLOGIX
    • GORE MEDICAL
    • LEMAITRE VASCULAR
    • LOMBARD MEDICAL TECHNOLOGY
    • TRIVASCULAR
    • VASCUTEK
  • MANUFACTURERS OF STENT GRAFTS FOR TEVAR
    • APTUS ENDOSYSTEMS
    • GORE MEDICAL
    • MEDTRONIC
  • GLOBAL MARKET FOR AORTIC ANEURYSM STENT GRAFTS
  • FIGURE 3 ESTIMATED MARKET SHARE OF AORTIC ANEURYSM STENT GRAFTS BY GEOGRAPHIC REGION, 2012 (%)
  • TABLE 7 PROJECTED GLOBAL MARKET FOR AORTIC ANEURYSM STENT GRAFTS, THROUGH 2018 ($ MILLIONS)

CHAPTER 7 GLOBAL MARKETS FOR PERCUTANEOUS ATHERECTOMY DEVICES FOR VASCULAR PROCEDURES

  • CLINICAL NEED FOR PERCUTANEOUS ATHERECTOMY
  • ATHERECTOMY PROCEDURE STATISTICS
  • TYPES OF PERCUTANEOUS ATHERECTOMY DEVICES
  • TABLE 8 POPULAR BRANDS OF PERCUTANEOUS ATHERECTOMY DEVICES
    • DIRECTIONAL ATHERECTOMY
    • LASER ATHERECTOMY
    • ROTATIONAL ATHERECTOMY
    • ORBITAL ATHERECTOMY
      • Cardiovascular Systems, Inc.
    • GLOBAL MARKET FOR PERCUTANEOUS ATHERECTOMY DEVICES
    • FIGURE 4 ESTIMATED MARKET SHARE OF PERCUTANEOUS ATHERECTOMY DEVICES BY GEOGRAPHIC REGION, 2012 (%)
    • TABLE 9 PROJECTED GLOBAL MARKET FOR PERCUTANEOUS ATHERECTOMY DEVICES, THROUGH 2018 ($ MILLIONS)

CHAPTER 8 GLOBAL MARKETS FOR VASCULAR THROMBOLYSIS AND THROMBECTOMY SYSTEMS

  • CLINICAL NEED FOR THROMBOSIS REMOVAL
  • CATHETER-DIRECTED THROMBOLYSIS
  • SUCTION AND PERCUTANEOUS MECHANICAL THROMBECTOMY
  • TABLE 10 SUMMARY OF MANUAL ASPIRATION AND PERCUTANEOUS MECHANICAL THROMBECTOMY DEVICES
  • MANUFACTURERS OF CATHETER-DIRECTED THROMBOLYSIS SYSTEMS
    • ANGIODYNAMICS
    • ATRIUM MEDICAL
    • CONTROL MEDICAL TECHNOLOGY
    • MEDTRONIC
  • MANUFACTURERS OF THROMBECTOMY SYSTEMS
    • BAYER INTERVENTIONAL
    • COVIDIEN
    • EKOS CORP.
    • SPECTRANETICS
    • VASCULAR INSIGHTS
  • GLOBAL MARKET FOR THROMBOLYSIS AND THROMBECTOMY SYSTEMS
  • FIGURE 5 ESTIMATED MARKET SHARE OF THROMBOLYSIS AND THROMBECTOMY SYSTEMS BY GEOGRAPHIC REGION, 2012 (%)
  • TABLE 11 PROJECTED GLOBAL MARKET FOR THROMBOLYSIS AND THROMBECTOMY SYSTEMS, THROUGH 2018 ($ MILLIONS)

CHAPTER 9 GLOBAL MARKETS FOR VENOUS DISEASE TREATMENTS AND CLOSURE DEVICES

  • CLINICAL NEED FOR VENOUS DISEASE TREATMENT
  • NON-INVASIVE TREATMENT: COMPRESSION THERAPY
  • TREATMENTS FOR SUPERFICIAL VENOUS INSUFFICIENCY
  • TABLE 12 PROJECTED GLOBAL MARKET FOR SCLEROTHERAPY PRODUCTS, THROUGH 2018 ($ MILLIONS)
    • AMBULATORY PHLEBECTOMY
  • TREATMENTS FOR NON-SUPERFICIAL VENOUS INSUFFICIENCY
    • VEIN STRIPPING
    • ENDOVENOUS CLOSURE
      • Endovenous Radiofrequency Ablation
      • Endovenous Laser Ablation
        • AngioDynamics
        • Biolitec AG
        • CoolTouch Laser
        • Dornier MedTech America
        • Sciton
        • Vascular Solutions
  • OTHER VENOUS DISEASE THERAPIES
  • GLOBAL MARKET FOR ENDOVENOUS CLOSURE SYSTEMS
  • FIGURE 6 ESTIMATED MARKET SHARE OF ENDOVENOUS CLOSURE DEVICES BY GEOGRAPHIC REGION, 2012 (%)
  • TABLE 13 PROJECTED GLOBAL MARKET FOR ENDOVENOUS CLOSURE DEVICES, THROUGH 2018 ($ MILLIONS)

CHAPTER 10 GLOBAL MARKETS FOR VASCULAR GRAFTS AND PATCHES FOR PERIPHERAL BYPASS SURGERY AND AV ACCESS

  • CLINICAL NEED FOR VASCULAR GRAFTS AND PATCHES
    • PERIPHERAL BYPASS SURGERY
    • ARTERIO-VENOUS (AV) ACCESS FOR HEMODIALYSIS
  • ALLOGRAFTS FOR PERIPHERAL BYPASS SURGERY AND AV ACCESS
    • CRYOLIFE
    • LEMAITRE VASCULAR
  • SYNTHETIC GRAFTS AND PATCHES FOR PERIPHERAL BYPASS AND AV ACCESS
    • GORE MEDICAL
    • BARD PERIPHERAL VASCULAR
    • ATRIUM MEDICAL
    • LEMAITRE VASCULAR
    • TERUMO INTERVENTIONAL SYSTEMS
    • VASCULAR FLOW TECHNOLOGIES
  • GLOBAL MARKET FOR PERIPHERAL VASCULAR GRAFTS AND PATCHES
  • FIGURE 7 ESTIMATED MARKET SHARE OF VASCULAR GRAFTS AND PATCHES BY GEOGRAPHIC REGION, 2012 (%)
  • TABLE 14 PROJECTED GLOBAL MARKET FOR PERIPHERAL VASCULAR GRAFTS AND PATCHES, THROUGH 2018 ($ MILLIONS)

CHAPTER 11 GLOBAL MARKETS FOR EMBOLIC PROTECTION DEVICES

  • CLINICAL NEED FOR EMBOLIC PROTECTION
    • CAROTID ARTERY FILTERS
    • IVC (INFERIOR VENA CAVA) FILTERS
  • MANUFACTURERS OF EMBOLIC PROTECTION DEVICES
    • ABBOTT VASCULAR
    • BARD PERIPHERAL VASCULAR
    • BOSTON SCIENTIFIC
    • COOK MEDICAL
    • CORDIS ENDOVASCULAR
    • COVIDIEN
    • GORE MEDICAL
    • ANGIOSLIDE
  • GLOBAL MARKET FOR EMBOLIC PROTECTION DEVICES
  • FIGURE 8 ESTIMATED MARKET SHARE OF EMBOLIC PROTECTION DEVICES BY GEOGRAPHIC REGION, 2012 (%)
  • TABLE 15 PROJECTED GLOBAL MARKET FOR EMBOLIC PROTECTION DEVICES, THROUGH 2018 ($ MILLIONS)

CHAPTER 12 GLOBAL IMPLICATIONS OF PERIPHERAL VASCULAR DISEASE AND AVAILABILITY OF PERIPHERAL VASCULAR SURGERY

  • INTRODUCTION 116
  • TABLE 16 ADULT MORTALITY FROM CARDIOVASCULAR DISEASE AND DIABETES, BY WORLD REGION, 2008 (ADULTS AGED 30-70, RATE PER 100,000 POPULATION)
  • PERIPHERAL VASCULAR DISEASE IN THE U.S.
    • OVERVIEW
    • THE U.S. HEALTHCARE SYSTEM
    • U.S. MEDICAL DEVICE MARKET
    • MEDICAL DEVICE REGULATION IN THE U.S.
  • TABLE 17 RECENT FDA RECALLS OF VASCULAR SURGERY DEVICES, 2010-2013
  • PERIPHERAL VASCULAR DISEASE IN EUROPE
    • OVERVIEW
    • TABLE 18 DEATHS FROM CARDIOVASCULAR DISEASE BY COUNTRY, EUROPE, MALES ONLY, 2005-2010 (NUMBER/%)
    • EUROPEAN MEDICAL DEVICE MARKET
    • MEDICAL DEVICE REGULATION IN EUROPE
  • PERIPHERAL VASCULAR SURGERY IN THE ASIA-PACIFIC REGION
    • JAPANESE HEALTHCARE SYSTEM OVERVIEW
      • Medical Device Market Size in Japan
      • Medical Device Regulation in Japan
    • INDIAN HEALTHCARE SYSTEM OVERVIEW
      • Medical Device Market Size in India
      • Medical Device Regulation in India
    • CHINESE HEALTHCARE SYSTEM OVERVIEW
      • Medical Device Market Size in China
      • Medical Device Regulation in China

CHAPTER 13 U.S. PATENT ANALYSIS OF PERIPHERAL VASCULAR SURGERY DEVICES

  • PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY STENTS
  • TABLE 19 PTA STENT SYSTEMS AND RELATED DEVICE PATENTS, 2010-2013
  • ENDOVASCULAR STENT GRAFTS AND RELATED PRODUCTS FOR VASCULAR
  • ANEURYSM REPAIR
  • TABLE 20 ENDOVASCULAR STENT GRAFTS AND RELATED DEVICE PATENTS,
  • 2010-2013
  • ATHERECTOMY SYSTEMS AND RELATED DEVICES
  • TABLE 21 ATHERECTOMY SYSTEMS AND RELATED DEVICE PATENTS, 2010-2013
  • THROMBECTOMY SYSTEMS AND RELATED DEVICES
  • TABLE 22 THROMBECTOMY SYSTEMS AND RELATED DEVICE PATENTS, 2010-2013
  • VASCULAR GRAFTS AND RELATED DEVICES
  • TABLE 23 VASCULAR GRAFTS AND RELATED DEVICE PATENTS, 2010-2013

CHAPTER 14 MERGER AND ACQUISITION ACTIVITY IN VASCULAR SURGERY DEVICES

  • TABLE 24 U.S. VENTURE CAPITAL INVESTMENT ACTIVITY, MEDICAL DEVICES AND EQUIPMENT, 2011-Q3, 2013 ($ MILLIONS/NO. OF DEALS)
  • FIGURE 9 U.S. VENTURE CAPITAL ACTIVITY, AMOUNT INVESTED, Q1 2011 TO Q3
  • 2013 ($ MILLIONS)
  • TABLE 25 RECENT ACQUISITIONS OF VASCULAR SURGERY COMPANIES AND TECHNOLOGIES, 2011-2013

CHAPTER 15 COMPANY PROFILES

  • 480 BIOMEDICAL
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • ABBOTT VASCULAR
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 26 ABBOTT VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • ANGIODYNAMICS, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 27 ANGIODYNAMICS VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • ANGIOSLIDE, LTD.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • APTUS ENDOSYSTEMS
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 28 APTUS ENDOSYSTEMS VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • BARD PERIPHERAL VASCULAR, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 29 BARD PERIPHERAL VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • BAYER RADIOLOGY & INTERVENTIONAL
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 30 BAYER RADIOLOGY AND INTERVENTIONAL VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • BIOLITEC AG
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 31 BIOLITEC VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • BOSTON SCIENTIFIC CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 32 BOSTON SCIENTIFIC VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CARDIOVASCULAR SYSTEMS, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 33 CARDIOVASCULAR SYSTEMS, INC. VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CARDIVA MEDICAL, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 34 CARDIVA MEDICAL VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CONTROL MEDICAL TECHNOLOGY, LLC
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 35 CONTROL MEDICAL TECHNOLOGY VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • COOK MEDICAL, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 36 COOK MEDICAL VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • COOL TOUCH, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 37 COOLTOUCH VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CORDIS ENDOVASCULAR
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 38 CORDIS ENDOVASCULAR VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CORINDUS VASCULAR ROBOTICS
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • COVIDIEN
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 39 COVIDIEN VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • CRYOLIFE, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 40 CRYOLIFE VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • DORNIER MEDTECH AMERICA, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 41 DORNIER VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • EDWARDS LIFESCIENCES CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 42 EDWARDS LIFESCIENCES VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • ENDOLOGIX, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 43 ENDOLOGIX VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • GORE MEDICAL
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 44 GORE MEDICAL VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • HANSEN MEDICAL
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 45 HANSEN MEDICAL VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • LEMAITRE VASCULAR, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 46 LEMAITRE VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • LOMBARD MEDICAL TECHNOLOGIES, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 47 LOMBARD MEDICAL TECHNOLOGIES VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • MAQUET CARDIOVASCULAR, LLC
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 48 MAQUET CARDIOVASCULAR VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • MEDTRONIC CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 49 MEDTRONIC VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • SCITON TECHNOLOGIES, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 50 SCITON TECHNOLOGIES VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • SPECTRANETICS CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 51 SPECTRANETICS VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • TELEFLEX INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 52 TELEFLEX VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • TERUMO INTERVENTIONAL SYSTEMS
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 53 TERUMO INTERVENTIONAL VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • TRIVASCULAR, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • VASCULAR INSIGHTS, LLC
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS
  • VASCULAR SOLUTIONS, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 54 VASCULAR SOLUTIONS SURGERY PRODUCTS
    • FINANCIALS
  • VOLCANO CORP.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • TABLE 55 VOLCANO CORP. VASCULAR SURGERY PRODUCTS
    • FINANCIALS
  • ZORION MEDICAL, INC.
    • BUSINESS OVERVIEW
    • PRODUCTS
    • FINANCIALS

LIST OF TABLES

  • SUMMARY TABLE 1 PROJECTED GLOBAL MARKET FOR PERIPHERAL VASCULAR SURGICAL DEVICES, THROUGH 2018 ($ MILLIONS)
  • SUMMARY TABLE 2 ESTIMATED MARKET SHARES BY MANUFACTURER, 2012 ($ MILLIONS/%)
  • TABLE 1 LEADING PERIPHERAL VASCULAR DISEASE CONDITIONS
  • TABLE 2 INVASIVE TECHNIQUES FOR IMAGING THE VULNERABLE PLAQUE
  • TABLE 3 NONINVASIVE TECHNIQUE FOR IMAGING THE VULNERABLE PLAQUE
  • TABLE 4 ESTIMATED NUMBER OF PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE, U.S. ONLY, 2012
  • TABLE 5 PROJECTED GLOBAL MARKET FOR PTA CATHETERS, GUIDEWIRES, AND RELATED DEVICES, THROUGH 2018 ($ MILLIONS)
  • TABLE 6 PROJECTED GLOBAL MARKET FOR PERIPHERAL VASCULAR AND CAROTID ARTERY STENT SYSTEMS, THROUGH 2018 ($ MILLIONS)
  • TABLE 7 PROJECTED GLOBAL MARKET FOR AORTIC ANEURYSM STENT GRAFTS, THROUGH 2018 ($ MILLIONS)
  • TABLE 8 POPULAR BRANDS OF PERCUTANEOUS ATHERECTOMY DEVICES
  • TABLE 9 PROJECTED GLOBAL MARKET FOR PERCUTANEOUS ATHERECTOMY DEVICES, THROUGH 2018 ($ MILLIONS)
  • TABLE 10 SUMMARY OF MANUAL ASPIRATION AND PERCUTANEOUS MECHANICAL THROMBECTOMY DEVICES
  • TABLE 11 PROJECTED GLOBAL MARKET FOR THROMBOLYSIS AND THROMBECTOMY SYSTEMS, THROUGH 2018 ($ MILLIONS)
  • TABLE 12 PROJECTED GLOBAL MARKET FOR SCLEROTHERAPY PRODUCTS, THROUGH 2018 ($ MILLIONS)
  • TABLE 13 PROJECTED GLOBAL MARKET FOR ENDOVENOUS CLOSURE DEVICES, THROUGH 2018 ($ MILLIONS)
  • TABLE 14 PROJECTED GLOBAL MARKET FOR PERIPHERAL VASCULAR GRAFTS AND PATCHES, THROUGH 2018 ($ MILLIONS)
  • TABLE 15 PROJECTED GLOBAL MARKET FOR EMBOLIC PROTECTION DEVICES, THROUGH 2018 ($ MILLIONS)
  • TABLE 16 ADULT MORTALITY FROM CARDIOVASCULAR DISEASE AND DIABETES, BY WORLD REGION, 2008 (ADULTS AGED 30-70, RATE PER 100,000 POPULATION) 116
  • TABLE 17 RECENT FDA RECALLS OF VASCULAR SURGERY DEVICES, 2010-2013 119
  • TABLE 18 DEATHS FROM CARDIOVASCULAR DISEASE BY COUNTRY, EUROPE, MALES ONLY, 2005-2010 (NUMBER/%)
  • TABLE 19 PTA STENT SYSTEMS AND RELATED DEVICE PATENTS, 2010-2013
  • TABLE 20 ENDOVASCULAR STENT GRAFTS AND RELATED DEVICE PATENTS, 2010-2013
  • TABLE 21 ATHERECTOMY SYSTEMS AND RELATED DEVICE PATENTS, 2010-2013
  • TABLE 22 THROMBECTOMY SYSTEMS AND RELATED DEVICE PATENTS, 2010-2013
  • TABLE 23 VASCULAR GRAFTS AND RELATED DEVICE PATENTS, 2010-2013
  • TABLE 24 U.S. VENTURE CAPITAL INVESTMENT ACTIVITY, MEDICAL DEVICES AND EQUIPMENT, 2011-Q3, 2013 ($ MILLIONS/NO. OF DEALS)
  • TABLE 25 RECENT ACQUISITIONS OF VASCULAR SURGERY COMPANIES AND TECHNOLOGIES, 2011-2013
  • TABLE 26 ABBOTT VASCULAR SURGERY PRODUCTS
  • TABLE 27 ANGIODYNAMICS VASCULAR SURGERY PRODUCTS
  • TABLE 28 APTUS ENDOSYSTEMS VASCULAR SURGERY PRODUCTS
  • TABLE 29 BARD PERIPHERAL VASCULAR SURGERY PRODUCTS
  • TABLE 30 BAYER RADIOLOGY AND INTERVENTIONAL VASCULAR SURGERY PRODUCTS
  • TABLE 31 BIOLITEC VASCULAR SURGERY PRODUCTS
  • TABLE 32 BOSTON SCIENTIFIC VASCULAR SURGERY PRODUCTS
  • TABLE 33 CARDIOVASCULAR SYSTEMS, INC. VASCULAR SURGERY PRODUCTS
  • TABLE 34 CARDIVA MEDICAL VASCULAR SURGERY PRODUCTS
  • TABLE 35 CONTROL MEDICAL TECHNOLOGY VASCULAR SURGERY PRODUCTS
  • TABLE 36 COOK MEDICAL VASCULAR SURGERY PRODUCTS
  • TABLE 37 COOLTOUCH VASCULAR SURGERY PRODUCTS
  • TABLE 38 CORDIS ENDOVASCULAR VASCULAR SURGERY PRODUCTS
  • TABLE 39 COVIDIEN VASCULAR SURGERY PRODUCTS
  • TABLE 40 CRYOLIFE VASCULAR SURGERY PRODUCTS
  • TABLE 41 DORNIER VASCULAR SURGERY PRODUCTS
  • TABLE 42 EDWARDS LIFESCIENCES VASCULAR SURGERY PRODUCTS
  • TABLE 43 ENDOLOGIX VASCULAR SURGERY PRODUCTS
  • TABLE 44 GORE MEDICAL VASCULAR SURGERY PRODUCTS
  • TABLE 45 HANSEN MEDICAL VASCULAR SURGERY PRODUCTS
  • TABLE 46 LEMAITRE VASCULAR SURGERY PRODUCTS
  • TABLE 47 LOMBARD MEDICAL TECHNOLOGIES VASCULAR SURGERY PRODUCTS
  • TABLE 48 MAQUET CARDIOVASCULAR VASCULAR SURGERY PRODUCTS
  • TABLE 49 MEDTRONIC VASCULAR SURGERY PRODUCTS
  • TABLE 50 SCITON TECHNOLOGIES VASCULAR SURGERY PRODUCTS
  • TABLE 51 SPECTRANETICS VASCULAR SURGERY PRODUCTS
  • TABLE 52 TELEFLEX VASCULAR SURGERY PRODUCTS
  • TABLE 53 TERUMO INTERVENTIONAL VASCULAR SURGERY PRODUCTS
  • TABLE 54 VASCULAR SOLUTIONS SURGERY PRODUCTS
  • TABLE 55 VOLCANO CORP. VASCULAR SURGERY PRODUCTS

LIST OF FIGURES

  • SUMMARY FIGURE ESTIMATED MARKET SHARES BY WORLD REGION, 2012 AND PROJECTED 2018 (%)
  • FIGURE 1 ESTIMATED MARKET SHARE OF PTA CATHETERS AND RELATED PRODUCTS BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 2 ESTIMATED MARKET SHARE OF VASCULAR AND CAROTID ARTERY STENT SYSTEMS BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 3 ESTIMATED MARKET SHARE OF AORTIC ANEURYSM STENT GRAFTS BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 4 ESTIMATED MARKET SHARE OF PERCUTANEOUS ATHERECTOMY DEVICES BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 5 ESTIMATED MARKET SHARE OF THROMBOLYSIS AND THROMBECTOMY SYSTEMS BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 6 ESTIMATED MARKET SHARE OF ENDOVENOUS CLOSURE DEVICES BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 7 ESTIMATED MARKET SHARE OF VASCULAR GRAFTS AND PATCHES BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 8 ESTIMATED MARKET SHARE OF EMBOLIC PROTECTION DEVICES BY GEOGRAPHIC REGION, 2012 (%)
  • FIGURE 9 U.S. VENTURE CAPITAL ACTIVITY, AMOUNT INVESTED, Q1 2011 TO Q3 2013 ($ MILLIONS)
Back to Top